These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16288172)

  • 1. [Preliminary pilot study of cyproterone acetate for the treatment of aggressive behavior associated with severe dementia].
    Caparros-Lefebvre D; Dewailly D
    Rev Neurol (Paris); 2005 Nov; 161(11):1071-8. PubMed ID: 16288172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproterone to treat aggressivity in dementia: a clinical case and systematic review.
    Bolea-Alamanac BM; Davies SJ; Christmas DM; Baxter H; Cullum S; Nutt DJ
    J Psychopharmacol; 2011 Jan; 25(1):141-5. PubMed ID: 19942637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiandrogen treatment of aggressivity in men suffering from dementia.
    Amadeo M
    J Geriatr Psychiatry Neurol; 1996 Jul; 9(3):142-5. PubMed ID: 8873879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of aggressive behavior in patients with dementia.
    Kunik ME; Snow AL; Davila JA; McNeese T; Steele AB; Balasubramanyam V; Doody R; Schulz PE; Kalavar JS; Walder A; Morgan RO
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):40-7. PubMed ID: 20160208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
    Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
    Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
    J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
    Sommer OH; Aga O; Cvancarova M; Olsen IC; Selbaek G; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(2):155-63. PubMed ID: 19182483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study.
    Huertas D; López-Ibor Aliño JJ; Molina JD; Chamorro L; Balanza J; Jiménez MP; Hornillos M
    J Clin Psychiatry; 2007 Mar; 68(3):439-44. PubMed ID: 17388716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitated behavior in persons with dementia: the relationship between type of behavior, its frequency, and its disruptiveness.
    Cohen-Mansfield J
    J Psychiatr Res; 2008 Nov; 43(1):64-9. PubMed ID: 18394647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.
    Walther S; Mahlberg R; Eichmann U; Kunz D
    Psychopharmacology (Berl); 2006 May; 185(4):524-8. PubMed ID: 16521031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
    De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
    J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic approach to management of agitation associated with dementia.
    Kunik ME; Yudofsky SC; Silver JM; Hales RE
    J Clin Psychiatry; 1994 Feb; 55 Suppl():13-7. PubMed ID: 7915710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
    Chibnall JT; Tait RC; Harman B; Luebbert RA
    J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study).
    Yoon SJ; Choi SH; Na HR; Park KW; Kim EJ; Han HJ; Lee JH; Shim YS; Na DL
    Geriatr Gerontol Int; 2017 Mar; 17(3):494-499. PubMed ID: 27111084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
    Woodward MR; Harper DG; Stolyar A; Forester BP; Ellison JM
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):415-9. PubMed ID: 23597932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
    Mintzer JE; Brawman-Mintzer O
    J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.